STERIS (STE) Stock Overview
Provides infection prevention products and services worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
STE passed our risk checks.
STE Community Fair Values
Create NarrativeSee what 11 others think this stock is worth. Follow their fair value or set your own to get alerts.
STERIS plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$252.16 |
| 52 Week High | US$269.44 |
| 52 Week Low | US$204.90 |
| Beta | 1.04 |
| 1 Month Change | -1.81% |
| 3 Month Change | -4.49% |
| 1 Year Change | 12.96% |
| 3 Year Change | 30.74% |
| 5 Year Change | 37.79% |
| Change since IPO | 12,125.94% |
Recent News & Updates
Recent updates
STERIS: A Bump In The Road For A Reliable Name
Feb 06Here's Why STERIS (NYSE:STE) Has Caught The Eye Of Investors
Jan 09
Earnings Tell The Story For STERIS plc (NYSE:STE)
Dec 26Is STERIS (NYSE:STE) A Risky Investment?
Oct 27Calculating The Fair Value Of STERIS plc (NYSE:STE)
Aug 28STERIS (NYSE:STE) Is Paying Out A Larger Dividend Than Last Year
Aug 07Is There Now An Opportunity In STERIS plc (NYSE:STE)?
Jul 06Is Now The Time To Put STERIS (NYSE:STE) On Your Watchlist?
May 23Is There An Opportunity With STERIS plc's (NYSE:STE) 33% Undervaluation?
May 07Is STERIS (NYSE:STE) A Risky Investment?
Apr 19Risks To Shareholder Returns Are Elevated At These Prices For STERIS plc (NYSE:STE)
Apr 01Steris: AST Recovery Is Ongoing; Upgrading To 'Strong Buy'
Mar 22Steris Q2: Anticipating HSD Growth In AST, Upgrade To 'Buy'
Nov 18Steris: Dental Divestiture, Surgical Instrumentation Acquisition, But Overvalued
Sep 16
Robust Revenue Growth And Expanding Margins In The Medical Equipment Sector
Strong start to the fiscal year and gross margin improvements suggest underappreciated growth momentum and potential for expanding net margins.Steris: Q2 Numbers Solidify Buy Thesis
Aug 13Steris: Moving On, Losing Its Teeth
Apr 14Steris: Strong Healthcare Products Growth Coupled With Weak AST Business
Feb 17Shareholder Returns
| STE | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -4.0% | -2.1% | -0.07% |
| 1Y | 13.0% | -9.0% | 13.9% |
Return vs Industry: STE exceeded the US Medical Equipment industry which returned -9% over the past year.
Return vs Market: STE matched the US Market which returned 13.8% over the past year.
Price Volatility
| STE volatility | |
|---|---|
| STE Average Weekly Movement | 3.6% |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: STE has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: STE's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | 17,787 | Dan Carestio | www.steris.com |
STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
STERIS plc Fundamentals Summary
| STE fundamental statistics | |
|---|---|
| Market cap | US$24.73b |
| Earnings (TTM) | US$708.52m |
| Revenue (TTM) | US$5.83b |
Is STE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| STE income statement (TTM) | |
|---|---|
| Revenue | US$5.83b |
| Cost of Revenue | US$3.24b |
| Gross Profit | US$2.58b |
| Other Expenses | US$1.87b |
| Earnings | US$708.52m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 7.22 |
| Gross Margin | 44.32% |
| Net Profit Margin | 12.16% |
| Debt/Equity Ratio | 26.5% |
How did STE perform over the long term?
See historical performance and comparisonDividends
Does STE pay a reliable dividends?
See STE dividend history and benchmarks| STERIS dividend dates | |
|---|---|
| Ex Dividend Date | Feb 17 2026 |
| Dividend Pay Date | Mar 19 2026 |
| Days until Ex dividend | 8 days |
| Days until Dividend pay date | 38 days |
Does STE pay a reliable dividends?
See STE dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/02/08 08:16 |
| End of Day Share Price | 2026/02/06 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
STERIS plc is covered by 21 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Polark | Baird |
| Erin Wilson Wright | BofA Global Research |
| David Turkaly | Citizens JMP Securities, LLC |